AbbVie (ABBV) Long-Term Debt Repayments (2015 - 2025)

AbbVie (ABBV) has 11 years of Long-Term Debt Repayments data on file, last reported at $8.0 million in Q4 2025.

• Quarterly Long-Term Debt Repayments fell 99.86% year-over-year to $8.0 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $3.8 billion (down 69.92% YoY) and the FY2025 annual result came in at $6.8 billion, down 29.29% from the prior year.
• Long-Term Debt Repayments declined to $8.0 million in Q4 2025 per ABBV's latest filing, from $9.0 million in the prior quarter.
• Across five years, Long-Term Debt Repayments topped out at $6.9 billion in Q4 2022 and bottomed at $2.0 million in Q2 2022.
• The 5-year median for Long-Term Debt Repayments is $2.2 billion (2021), against an average of $2.3 billion.
• The widest annual swing landed in 2022, when Long-Term Debt Repayments tumbled 99.94%; it then jumped 50000.0% in 2023.
• Tracing ABBV's Long-Term Debt Repayments over 5 years: stood at $3.8 billion in 2021, then surged by 82.6% to $6.9 billion in 2022, then slumped by 73.81% to $1.8 billion in 2023, then surged by 221.18% to $5.8 billion in 2024, then sank by 99.86% to $8.0 million in 2025.
• Per Business Quant, the three latest ABBV Long-Term Debt Repayments figures stand at $8.0 million (Q4 2025), $9.0 million (Q3 2025), and $3.8 billion (Q2 2025).

Peer Comparison